文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

表面交联壳聚糖的立方液晶纳米粒对长春西汀具有缓释作用并能提高其生物利用度。

Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine.

作者信息

Wei Yuanfeng, Zhang Jianjun, Zheng Yazhen, Gong Yaxiang, Fu Meng, Liu Chengran, Xu Liang, Sun Changquan Calvin, Gao Yuan, Qian Shuai

机构信息

School of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 210009 China

School of Pharmacy, China Pharmaceutical University Nanjing 210009 China.

出版信息

RSC Adv. 2019 Feb 21;9(11):6287-6298. doi: 10.1039/c8ra10302j. eCollection 2019 Feb 18.


DOI:10.1039/c8ra10302j
PMID:35517286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9060951/
Abstract

The present study aims to develop cubosomes with surface cross-linked chitosan for sustained drug delivery and enhanced oral bioavailability of vinpocetine (VPT). GMO based liquid cubosomes with VPT loading were prepared by the high pressure homogenization method. In order to enhance the anti-digestion effect, chitosan was cross-linked on cubosomes by the Schiff reaction, followed by solidification spray drying. The obtained spray-dried cubosomes (chito-cubosomes) are spherical microspheres with nano-sized holes on the surface. After reconstitution, the particle size and zeta potential of chito-cubosomes were determined to be ∼250 nm and +35.9 mV, respectively. In comparison to unmodified liquid cubosomes, chito-cubosomes exhibited a significant anti-digestion effect with a typical sustained release profile. In comparison to a VPT suspension, liquid cubosomes showed a 2.5-fold higher and 3.0-fold higher AUC, while chito-cubosomes further enhanced bioavailability (5.0-fold) with prolonged MRT (2.2-fold) and delayed (2.8-fold). The results suggested that chito-cubosomes could be a promising drug carrier for enhancing oral absorption with sustained release behavior.

摘要

本研究旨在开发具有表面交联壳聚糖的立方液晶纳米粒,用于长春西汀(VPT)的持续给药并提高其口服生物利用度。采用高压均质法制备了负载VPT的转基因液体立方液晶纳米粒。为增强抗消化作用,通过席夫反应使壳聚糖在立方液晶纳米粒上交联,随后进行固化喷雾干燥。所得喷雾干燥立方液晶纳米粒(壳聚糖立方液晶纳米粒)为表面带有纳米级孔洞的球形微球。复溶后,壳聚糖立方液晶纳米粒的粒径和ζ电位分别测定为约250 nm和+35.9 mV。与未修饰的液体立方液晶纳米粒相比,壳聚糖立方液晶纳米粒表现出显著的抗消化作用及典型的缓释特征。与VPT混悬液相比,液体立方液晶纳米粒的AUC高出2.5倍,Cmax高出3.0倍,而壳聚糖立方液晶纳米粒进一步提高了生物利用度(5.0倍),延长了平均滞留时间(2.2倍)并延迟了Tmax(2.8倍)。结果表明,壳聚糖立方液晶纳米粒可能是一种有前景的药物载体,可增强口服吸收并具有缓释行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/35e9b0d5b79d/c8ra10302j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/3e241483440f/c8ra10302j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/2d802103b6e3/c8ra10302j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/a92e8b469537/c8ra10302j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/d86ffda57b18/c8ra10302j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/1c7bebb08dc3/c8ra10302j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/6fb5ecd0c4ac/c8ra10302j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/fc4a163e0d68/c8ra10302j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/af3927ee77d8/c8ra10302j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/35e9b0d5b79d/c8ra10302j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/3e241483440f/c8ra10302j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/2d802103b6e3/c8ra10302j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/a92e8b469537/c8ra10302j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/d86ffda57b18/c8ra10302j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/1c7bebb08dc3/c8ra10302j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/6fb5ecd0c4ac/c8ra10302j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/fc4a163e0d68/c8ra10302j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/af3927ee77d8/c8ra10302j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9e1/9060951/35e9b0d5b79d/c8ra10302j-f9.jpg

相似文献

[1]
Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine.

RSC Adv. 2019-2-21

[2]
Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.

Pharm Dev Technol. 2017-5

[3]
Dual cross-linked chitosan microspheres formulated with spray-drying technique for the sustained release of levofloxacin.

Drug Dev Ind Pharm. 2019-1-31

[4]
Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.

Acta Pharmacol Sin. 2010-8

[5]
Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.

Drug Deliv. 2017-11

[6]
Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes.

Chem Pharm Bull (Tokyo). 2017

[7]
Preparation and Evaluation of Cubosomes/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis.

Pharm Res. 2020-9-23

[8]
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.

J Control Release. 2011-4-8

[9]
Freeze-Dried Clopidogrel Loaded Lyotropic Liquid Crystal: Box-Behnken Optimization, and Evaluation.

Curr Drug Deliv. 2020

[10]
PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.

Drug Deliv. 2023-12

引用本文的文献

[1]
Development of Chitosan-Coated Atorvastatin-Loaded Liquid Crystalline Nanoparticles: Intersection of Drug Repurposing and Nanotechnology in Colorectal Cancer Management.

Pharmaceutics. 2025-5-27

[2]
Eco-friendly Nanostructured Liquid Crystals Loaded with Clove Oil as a Sustainable Approach for Managing Infected Burn Wounds.

AAPS PharmSciTech. 2024-12-17

[3]
Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.

J Lipids. 2024-7-10

[4]
Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals.

Liquids (Basel). 2023-12

[5]
Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.

Naunyn Schmiedebergs Arch Pharmacol. 2024-6

[6]
Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: Recent advances in synergistic strategies for maximizing control of high-risk type II diabetes.

Drug Deliv Transl Res. 2024-3

[7]
Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines.

Int J Pharm X. 2023-8-25

[8]
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery.

ACS Omega. 2022-12-20

[9]
Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation.

Int J Nanomedicine. 2022

[10]
A Versatile Nanocarrier-Cubosomes, Characterization, and Applications.

Nanomaterials (Basel). 2022-6-29

本文引用的文献

[1]
Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.

Colloids Surf B Biointerfaces. 2017-10-12

[2]
Synthesis and characterisation of cross-linked chitosan composites functionalised with silver and gold nanoparticles for antimicrobial applications.

Sci Technol Adv Mater. 2017-7-20

[3]
Synthesis of oxidized glycerol monooleate-chitosan polymer and its hydrogel formation for sustained release of trimetazidine hydrochloride.

Int J Pharm. 2014-2-7

[4]
Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.

Pharmaceutics. 2012-8-13

[5]
Bioavailability enhancement of glucosamine hydrochloride by chitosan.

Int J Pharm. 2013-7-3

[6]
The morphology of silver nanoparticles prepared by enzyme-induced reduction.

Beilstein J Nanotechnol. 2012-5-18

[7]
Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.

Int J Biomater. 2012

[8]
Chitosan coated liposomes as an innovative nanocarrier for drugs.

J Biomed Nanotechnol. 2012-4

[9]
Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats.

J Pharm Biomed Anal. 2011-12-3

[10]
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.

J Control Release. 2011-4-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索